182 related articles for article (PubMed ID: 16499313)
1. Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
Turbyville TJ; Wijeratne EM; Liu MX; Burns AM; Seliga CJ; Luevano LA; David CL; Faeth SH; Whitesell L; Gunatilaka AA
J Nat Prod; 2006 Feb; 69(2):178-84. PubMed ID: 16499313
[TBL] [Abstract][Full Text] [Related]
2. Uncovering biosynthetic potential of plant-associated fungi: effect of culture conditions on metabolite production by Paraphaeosphaeria quadriseptata and Chaetomium chiversii.
Paranagama PA; Wijeratne EM; Gunatilaka AA
J Nat Prod; 2007 Dec; 70(12):1939-45. PubMed ID: 18052326
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the biosynthesis of radicicol, an Hsp90 inhibitor resorcylic acid lactone from Chaetomium chiversii.
Wang S; Xu Y; Maine EA; Wijeratne EM; Espinosa-Artiles P; Gunatilaka AA; Molnár I
Chem Biol; 2008 Dec; 15(12):1328-38. PubMed ID: 19101477
[TBL] [Abstract][Full Text] [Related]
4. A rhizosphere fungus enhances Arabidopsis thermotolerance through production of an HSP90 inhibitor.
McLellan CA; Turbyville TJ; Wijeratne EM; Kerschen A; Vierling E; Queitsch C; Whitesell L; Gunatilaka AA
Plant Physiol; 2007 Sep; 145(1):174-82. PubMed ID: 17631526
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific antitumor activity of radicicol oxime derivatives.
Soga S; Sharma SV; Shiotsu Y; Shimizu M; Tahara H; Yamaguchi K; Ikuina Y; Murakata C; Tamaoki T; Kurebayashi J; Schulte TW; Neckers LM; Akinaga S
Cancer Chemother Pharmacol; 2001 Dec; 48(6):435-45. PubMed ID: 11800023
[TBL] [Abstract][Full Text] [Related]
6. Monocillin II inhibits human breast cancer growth partially by inhibiting MAPK pathways and CDK2 Thr160 phosphorylation.
Wei H; Xu L; Yu M; Zhang L; Wang H; Wei X; Ruan Y
Chembiochem; 2012 Feb; 13(3):465-75. PubMed ID: 22253097
[TBL] [Abstract][Full Text] [Related]
7. Development of radicicol analogues.
Soga S; Shiotsu Y; Akinaga S; Sharma SV
Curr Cancer Drug Targets; 2003 Oct; 3(5):359-69. PubMed ID: 14529387
[TBL] [Abstract][Full Text] [Related]
8. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide.
Clevenger RC; Blagg BS
Org Lett; 2004 Nov; 6(24):4459-62. PubMed ID: 15548050
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Hsp90 with synthetic macrolactones: synthesis and structural and biological evaluation of ring and conformational analogs of radicicol.
Proisy N; Sharp SY; Boxall K; Connelly S; Roe SM; Prodromou C; Slawin AM; Pearl LH; Workman P; Moody CJ
Chem Biol; 2006 Nov; 13(11):1203-15. PubMed ID: 17114002
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of HSP90 inhibitors based on conformational analysis of radicicol and its analogues.
Moulin E; Zoete V; Barluenga S; Karplus M; Winssinger N
J Am Chem Soc; 2005 May; 127(19):6999-7004. PubMed ID: 15884943
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90.
Shen G; Wang M; Welch TR; Blagg BS
J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666
[TBL] [Abstract][Full Text] [Related]
13. New efficient synthesis of resorcinylic macrolides via ynolides: establishment of cycloproparadicicol as synthetically feasible preclinical anticancer agent based on Hsp90 as the target.
Yang ZQ; Geng X; Solit D; Pratilas CA; Rosen N; Danishefsky SJ
J Am Chem Soc; 2004 Jun; 126(25):7881-9. PubMed ID: 15212536
[TBL] [Abstract][Full Text] [Related]
14. Radicicol represses the transcriptional function of the estrogen receptor by suppressing the stabilization of the receptor by heat shock protein 90.
Lee MO; Kim EO; Kwon HJ; Kim YM; Kang HJ; Kang H; Lee JE
Mol Cell Endocrinol; 2002 Feb; 188(1-2):47-54. PubMed ID: 11911945
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Roe SM; Prodromou C; O'Brien R; Ladbury JE; Piper PW; Pearl LH
J Med Chem; 1999 Jan; 42(2):260-6. PubMed ID: 9925731
[TBL] [Abstract][Full Text] [Related]
16. Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin.
Fedier A; Stuedli A; Fink D
Int J Oncol; 2005 Dec; 27(6):1697-705. PubMed ID: 16273226
[TBL] [Abstract][Full Text] [Related]
17. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin.
Hadden MK; Blagg BS
J Org Chem; 2009 Jul; 74(13):4697-704. PubMed ID: 19492825
[TBL] [Abstract][Full Text] [Related]
19. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
[TBL] [Abstract][Full Text] [Related]
20. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
